Synapse - Center for Hematologic Malignancies

Results (13553)

Specific and recurrent cytogenomic abnormalities originate in the spleens of myelofibrosis patients and contribute to clonal diversity and disease progression

Meeting Abstract

Najfeld, V.; Tripodi, J.; Wang, X. L.; Schwartz, M.; Kremyanskaya, M.; Cytryn, E.; Zirkiev, S.; Rampal, R. K.; Mascarenhas, J. O.; Hoffman, R.
Blood (2014)

Fulltext@MSK | Save

Prediction of CD34(+) hematopoietic progenitor cell harvest yield in multiple myeloma patients mobilized with G-CF and plerixafor

Meeting Abstract

Moung, C.; Avecilla, S. T.; Meagher, R. C.; Reich, L.; Maslak, P.
Transfusion (2014)

Fulltext@MSK | Save

Interim analysis of a phase 1 study of the antibody-drug conjugate SGN-CD19A in relapsed or refractory B-lineage non-Hodgkin lymphoma

Meeting Abstract

Moskowitz, C. H.; Forero-Torres, A.; Shah, B. D.; Advani, R.; Hamlin, P.; Kim, S.; Kostic, A.; Sandalic, L.; Zhao, B. T.; Fanale, M. A.
Blood (2014)

Fulltext@MSK | Save

Type II inhibition of JAK2 with NVP-CHZ868 reverses type I JAK inhibitor persistence and demonstrates increased efficacy in MPN models

Meeting Abstract

Meyer, S. C.; Keller, M. D.; Koppikar, P.; Guryanova, O. A.; Kleppe, M.; McKenney, A. S.; Sellers, W. R.; Hofmann, F.; Baffert, F.; Gaul, C.; more...
Blood (2014)

Fulltext@MSK | Save

Distinct DNA methylation and expression profiles underlie CMML responsiveness to decitabine and uncover novel mechanism of resistance

Meeting Abstract

Meldi, K.; Qin, T. T.; Buchi, F.; Micol, J. B.; Sotzen, J.; Masala, E.; Allione, B.; Gioia, D.; Poloni, A.; Lunghi, M.; more...
Blood (2014)

Fulltext@MSK | Save

Deep molecular response in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) treated with nilotinib: ENESTnext update

Meeting Abstract

Mauro, M. J.; Dakhil, S.; Cortes, J. E.; Rizzieri, D. A.; Keir, C. H.; Yi, S.; Heinrich, M. C.; Goldberg, S. L.; Catchatourian, R.; Kuriakose, P.; more...
Blood (2014)

Fulltext@MSK | Save

Ponatinib efficacy and safety in patients with the T315I mutation: Long-term follow-up of phase 1 and phase 2 (PACE) trials

Meeting Abstract

Mauro, M. J.; Cortes, J. E.; Hochhaus, A.; Baccarani, M.; Hughes, T. P.; Guilhot, F.; Deininger, M. W.; Kantarjian, H. M.; Shah, N. P.; Bixby, D.; more...
Blood (2014)

Fulltext@MSK | Save

Cytogenetic and molecular responses in patients with chronic-phase chronic myeloid leukemia (CP-CML) in a prospective observational study (SIMPLICITY)

Meeting Abstract

Mauro, M.; Gambacorti-Passerini, C.; Goldberg, S. L.; Cortes, J. E.; Khoury, H. J.; Michallet, M.; Paquette, R.; Simonsson, B.; Turner, M. P.; Mohamed, H.; more...
Blood (2014)

Fulltext@MSK | Save

Extended use of rituximab in older adults with non-Hodgkin lymphoma

Meeting Abstract

Matasar, M. J.; Atoria, C. L.; Elkin, E. B.; Nabhan, C.
Blood (2014)

Fulltext@MSK | Save

A phase Ib dose escalation trial of SAR650984 (anti-CD-38 mAb) in combination with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma

Meeting Abstract

Martin, T. G.; Baz, R.; Benson, D. M.; Lendvai, N.; Campana, F.; Charpentier, E.; Vij, R.
Blood (2014)

Fulltext@MSK | Save